Annual EBITDA
-$41.81 M
+$18.91 M+31.15%
December 31, 2023
Summary
- As of February 8, 2025, EOLS annual EBITDA is -$41.81 million, with the most recent change of +$18.91 million (+31.15%) on December 31, 2023.
- During the last 3 years, EOLS annual EBITDA has risen by +$102.94 million (+71.12%).
- EOLS annual EBITDA is now -263.31% below its all-time high of -$11.51 million, reached on December 31, 2017.
Performance
EOLS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$13.00 M
-$7.97 M-158.42%
September 30, 2024
Summary
- As of February 8, 2025, EOLS quarterly EBITDA is -$13.00 million, with the most recent change of -$7.97 million (-158.42%) on September 30, 2024.
- Over the past year, EOLS quarterly EBITDA has dropped by -$1.36 million (-11.73%).
- EOLS quarterly EBITDA is now -240.45% below its all-time high of $9.26 million, reached on March 31, 2021.
Performance
EOLS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$30.97 M
-$1.36 M-4.61%
September 30, 2024
Summary
- As of February 8, 2025, EOLS TTM EBITDA is -$30.97 million, with the most recent change of -$1.36 million (-4.61%) on September 30, 2024.
- Over the past year, EOLS TTM EBITDA has increased by +$13.96 million (+31.07%).
- EOLS TTM EBITDA is now -759.51% below its all-time high of -$3.60 million, reached on December 31, 2016.
Performance
EOLS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EOLS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.1% | -11.7% | +31.1% |
| 3 y3 years | +71.1% | -11.7% | +31.1% |
| 5 y5 years | +9.0% | -11.7% | +31.1% |
EOLS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.0% | +31.1% | -158.4% | +36.0% | -4.6% | +55.5% |
| 5 y | 5-year | -7.0% | +71.1% | -240.4% | +87.7% | -4.6% | +78.6% |
| alltime | all time | -263.3% | +71.1% | -240.4% | +87.7% | -759.5% | +78.6% |
Evolus EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.00 M(+158.4%) | -$30.97 M(+4.6%) |
| Jun 2024 | - | -$5.03 M(-26.0%) | -$29.60 M(-22.2%) |
| Mar 2024 | - | -$6.80 M(+10.9%) | -$38.05 M(-9.0%) |
| Dec 2023 | -$41.81 M(-31.1%) | -$6.13 M(-47.3%) | -$41.81 M(-6.9%) |
| Sep 2023 | - | -$11.64 M(-13.6%) | -$44.92 M(-10.3%) |
| Jun 2023 | - | -$13.47 M(+27.5%) | -$50.09 M(-12.0%) |
| Mar 2023 | - | -$10.57 M(+14.3%) | -$56.94 M(-6.2%) |
| Dec 2022 | -$60.72 M(+55.5%) | -$9.25 M(-45.0%) | -$60.72 M(-11.2%) |
| Sep 2022 | - | -$16.80 M(-17.3%) | -$68.40 M(-1.7%) |
| Jun 2022 | - | -$20.32 M(+41.7%) | -$69.61 M(+11.1%) |
| Mar 2022 | - | -$14.35 M(-15.2%) | -$62.66 M(+60.4%) |
| Dec 2021 | -$39.06 M(-73.0%) | -$16.93 M(-6.0%) | -$39.06 M(-69.5%) |
| Sep 2021 | - | -$18.01 M(+34.7%) | -$128.11 M(+9.6%) |
| Jun 2021 | - | -$13.38 M(-244.5%) | -$116.92 M(-2.9%) |
| Mar 2021 | - | $9.26 M(-108.7%) | -$120.39 M(-16.8%) |
| Dec 2020 | -$144.75 M | -$105.98 M(+1453.1%) | -$144.75 M(+193.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$6.82 M(-59.5%) | -$49.30 M(-25.0%) |
| Jun 2020 | - | -$16.84 M(+11.5%) | -$65.77 M(-20.8%) |
| Mar 2020 | - | -$15.10 M(+43.4%) | -$83.03 M(-9.9%) |
| Dec 2019 | -$92.10 M(+100.5%) | -$10.53 M(-54.8%) | -$92.10 M(-1.9%) |
| Sep 2019 | - | -$23.30 M(-31.7%) | -$93.88 M(+14.4%) |
| Jun 2019 | - | -$34.10 M(+41.0%) | -$82.07 M(+28.1%) |
| Mar 2019 | - | -$24.18 M(+96.5%) | -$64.06 M(+39.5%) |
| Dec 2018 | -$45.93 M(+299.1%) | -$12.30 M(+7.1%) | -$45.93 M(+25.9%) |
| Sep 2018 | - | -$11.49 M(-28.6%) | -$36.48 M(+32.1%) |
| Jun 2018 | - | -$16.10 M(+166.3%) | -$27.61 M(+101.8%) |
| Mar 2018 | - | -$6.04 M(+111.5%) | -$13.69 M(+18.9%) |
| Dec 2017 | -$11.51 M(-41.4%) | -$2.86 M(+9.3%) | -$11.51 M(-6.1%) |
| Sep 2017 | - | -$2.62 M(+20.7%) | -$12.25 M(+27.1%) |
| Jun 2017 | - | -$2.17 M(-43.9%) | -$9.64 M(+29.0%) |
| Mar 2017 | - | -$3.87 M(+7.3%) | -$7.47 M(+107.3%) |
| Dec 2016 | -$19.64 M(-35.7%) | -$3.60 M | -$3.60 M |
| Dec 2015 | -$30.56 M | - | - |
FAQ
- What is Evolus annual EBITDA?
- What is the all time high annual EBITDA for Evolus?
- What is Evolus annual EBITDA year-on-year change?
- What is Evolus quarterly EBITDA?
- What is the all time high quarterly EBITDA for Evolus?
- What is Evolus quarterly EBITDA year-on-year change?
- What is Evolus TTM EBITDA?
- What is the all time high TTM EBITDA for Evolus?
- What is Evolus TTM EBITDA year-on-year change?
What is Evolus annual EBITDA?
The current annual EBITDA of EOLS is -$41.81 M
What is the all time high annual EBITDA for Evolus?
Evolus all-time high annual EBITDA is -$11.51 M
What is Evolus annual EBITDA year-on-year change?
Over the past year, EOLS annual EBITDA has changed by +$18.91 M (+31.15%)
What is Evolus quarterly EBITDA?
The current quarterly EBITDA of EOLS is -$13.00 M
What is the all time high quarterly EBITDA for Evolus?
Evolus all-time high quarterly EBITDA is $9.26 M
What is Evolus quarterly EBITDA year-on-year change?
Over the past year, EOLS quarterly EBITDA has changed by -$1.36 M (-11.73%)
What is Evolus TTM EBITDA?
The current TTM EBITDA of EOLS is -$30.97 M
What is the all time high TTM EBITDA for Evolus?
Evolus all-time high TTM EBITDA is -$3.60 M
What is Evolus TTM EBITDA year-on-year change?
Over the past year, EOLS TTM EBITDA has changed by +$13.96 M (+31.07%)